NCT01779024View on ClinicalTrials.gov

Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 13, 2012

Primary Completion Date

June 1, 2017

Study Completion Date

June 1, 2017

Conditions
fMRIAlcohol DrinkingAlcoholism
Interventions
DRUG

Ghrelin

DRUG

Placebo

PROCEDURE

fMRI

DRUG

Alcohol

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

NCT01779024 - Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers | Biotech Hunter | Biotech Hunter